Coming Soon: CMS to Provide $50 Monthly Access to GLP-1 Medications for Medicare Beneficiaries
Article Publication Date
Summary
Starting July 1, 2026, CMS will provide eligible Medicare beneficiaries with access to certain GLP-1 medications at a $50 monthly cost. Under the Medicare GLP-1 Bridge, a time-limited demonstration, CMS is expanding access to evidence-based weight-loss treatments. Eligible individuals enrolled in Medicare Part D prescription drug plans will be able to access these medications.
The Medicare GLP-1 Bridge operates under the Secretary’s authority to test new approaches to care delivery under Medicare and is supported by CMS, including centralized processes for claims adjudication and payment to pharmacies. The program runs through December 2027.
The Medicare GLP-1 Bridge operates under the Secretary’s authority to test new approaches to care delivery under Medicare and is supported by CMS, including centralized processes for claims adjudication and payment to pharmacies. The program runs through December 2027.